"Aethlon Medical treats first subject with Hemopurifier device in Australia" was originally created and published by Medical ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the ...

Aligning therapies with the biologic clock may improve efficacy, as macrophage activity peaks early in the morning, worsening inflammatory disease symptoms.

Sepsis is a life-threatening condition that can occur when the body is trying to fight an infection. Now scientists know more about it. | Microbiology ...

Find out why stress can worsen allergy symptoms. Learn about the cellular chain reaction that occurs in the body and how it ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

Many changes happen to the body once a person passes 80 years of age. Recent research hints at aging's unexpected effect on ...

The latest findings on the interaction between cell death and cellular senescence in cancer and their pathophysiological significance have been reviewed.